When leukemia spreads to the lungs, the abnormal white blood cells that normally crowd the bone marrow and bloodstream begin infiltrating lung tissue, triggering a cascade of problems that can range from mild breathlessness to life-threatening respiratory failure. Unlike solid tumors that form distinct masses, leukemia cells tend to seep through tiny blood vessels and settle in the delicate tissue between air sacs, disrupting the lungs’ ability to exchange oxygen. The consequences depend on the type of leukemia, how many abnormal cells are circulating, and whether complications like bleeding or infection develop alongside the infiltration itself.
How Leukemia Cells Get Into Lung Tissue
The lungs are uniquely vulnerable to leukemia spread because of their anatomy. The air sacs, called alveoli, are surrounded by an extremely thin network of blood vessels designed to let oxygen and carbon dioxide pass easily between inhaled air and the bloodstream. That same thinness makes it relatively easy for leukemia cells to leak through. Research examining lung tissue from both mice and patients with acute myeloid leukemia (AML) has shown that cancer cells slip through these thin alveolar wall blood vessels and spill into the surrounding connective tissue, or stroma.1Nature Immunology. What Happens When Leukemia Spreads to the Lungs? Once there, the cells can spread along the tissue scaffolding of the lung, thickening the walls between air sacs and making gas exchange progressively harder.
This pattern of spread differs from what you might picture with lung cancer. There is usually no single tumor to point to on an X-ray. Instead, leukemia cells infiltrate diffusely, sometimes concentrating around blood vessels and lymphatic channels throughout both lungs. That diffuse pattern is one reason the problem can be so difficult to diagnose and so dangerous when it escalates quickly.
Leukostasis and the White-Cell Traffic Jam
One of the most acute emergencies connected to leukemia in the lungs is leukostasis. This happens when the circulating white blood cell count climbs extremely high and abnormal cells begin clogging the tiny blood vessels of the lungs. Early thinking attributed the problem simply to overcrowding in the capillaries, but the reality is more complex. The leukemia cells damage the blood vessel lining directly, partly through chemical signals (cytokines) released during the interaction between the cancer cells and the vessel walls, and partly through the cells’ ability to burrow through into surrounding tissue.2PubMed. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management Whether leukostasis develops depends less on the raw number of circulating cells and more on the cells’ biological stickiness and their responsiveness to chemical signals that pull them toward the vessel walls.
Clinically, leukostasis in the lungs can cause sudden, severe shortness of breath that worsens rapidly. It is most commonly associated with AML, particularly monocytic subtypes, and one study of 20 patients admitted to intensive care found that rapidly progressive respiratory distress was a revealing feature, with a median white blood cell count near 100,000 per cubic millimeter and respiratory symptoms starting just days before ICU admission.3American Journal of Respiratory and Critical Care Medicine. Acute Monocytic Leukemia Presenting as Acute Respiratory Failure This is an emergency situation. The primary goal is to reduce the white cell count as fast as possible. Treatment typically relies on hydroxyurea and chemotherapy, and updated guidelines from the American Society for Apheresis have found limited evidence that adding leukapheresis (a procedure that physically filters white cells from the blood) improves outcomes compared to hydroxyurea alone.4Blood. Comparison of Cytoreductive Therapies for Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: A Perspective on the Updated American Society for Apheresis Guidelines
The prognosis for patients who develop pulmonary leukostasis is grim. A study of patients with AML and very high white cell counts found that those with lung leukostasis had a remission rate of only about 27%, compared to 64% in patients without it, and a median survival of just days rather than months. The authors concluded that pulmonary leukostasis was the single worst prognostic factor in the group.5The American Journal of Medicine. Pulmonary leukostasis as the single worst prognostic factor in patients with acute myelocytic leukemia and hyperleukocytosis
What Symptoms to Expect
Pulmonary involvement in leukemia does not always announce itself loudly. The type and severity of symptoms depend on how extensively the lungs are affected and whether the problem is direct infiltration, leukostasis, or a secondary complication like infection or bleeding. In a study of patients with chronic lymphocytic leukemia (CLL) who had confirmed leukemic lung infiltrates, the most common symptoms were shortness of breath (affecting about 62% of patients), cough (about 54%), and fatigue (about 46%). Roughly 15% of patients had no symptoms at all, with the lung involvement discovered incidentally on imaging.6PubMed. Leukemic pulmonary infiltrates in chronic lymphocytic leukemia: Clinical and imaging features
At the other extreme, some patients present with catastrophic respiratory failure. Case reports describe patients with acute leukemia who developed progressive breathlessness that rapidly escalated to acute respiratory distress syndrome, or ARDS, a condition where the lungs become so inflamed and flooded that mechanical ventilation is required.7PubMed. Acute respiratory distress syndrome caused by leukemic infiltration of the lung This wide spectrum, from silent to deadly, is part of what makes lung involvement in leukemia so unpredictable.
What Imaging Shows
CT scans of leukemic lung infiltrates reveal patterns that reflect how the cancer cells spread through the lung’s supporting framework. High-resolution CT typically shows changes concentrated along the network of tissue surrounding blood vessels and lymphatic channels, because that is where leukemia cells preferentially settle.8PubMed. Pulmonary leukemic infiltrates: high-resolution CT findings in 10 patients The specific appearances include hazy patches called ground-glass opacities, small nodules branching outward in a “tree-in-bud” pattern, thickened tissue around airways and blood vessels, and areas of denser consolidation.9PubMed Central. Direct pulmonary infiltrates as an initial manifestation of chronic lymphocytic leukemia
Studies across different leukemia subtypes show consistent imaging themes. In adult T-cell leukemia, for example, CT findings in dozens of patients included ground-glass haze, small nodules near the centers of lung lobules, thickened tissue around airways, and consolidation, predominantly in the outer parts of the lungs. Pathology confirmed that these findings corresponded to leukemia cells infiltrating the tissue between air sacs and within the air spaces themselves.10PubMed. Thoracic CT findings of adult T-cell leukemia or lymphoma None of these patterns are unique to leukemia, though, which is the central diagnostic problem.
Why Leukemic Lung Infiltrates Are So Hard to Diagnose
The imaging appearances of leukemia in the lungs overlap heavily with infection, particularly fungal infections. Patients with leukemia are deeply immunosuppressed, either from the disease itself or from chemotherapy, so lung infections are extremely common. When a CT scan shows new patches of consolidation or hazy opacities, the default assumption is often infection, and for good reason. But sometimes those changes turn out to be leukemia cells rather than germs.
One case report illustrates this vividly: a 69-year-old man with AML developed a fever, and his CT showed consolidation that looked suspicious for invasive fungal infection such as aspergillosis. Specialized biopsy techniques eventually proved the problem was actually leukemic infiltration of the lung, not fungus at all.11PubMed Central. Diagnosis of leukemic lung infiltration mimicking fungal infection by transbronchial lung cryobiopsy: the first case report This distinction matters enormously because the treatments are opposite: antifungals for infection versus chemotherapy for leukemic infiltration.
Clinicians approach the problem by considering the pattern of imaging findings (whether the infiltrates are focal or diffuse) and the timing relative to chemotherapy. Localized infiltrates appearing early in treatment are most often bacterial infections, while those appearing later tend to be fungal. Diffuse infiltrates that appear early can signal leukemic infiltration, bleeding into the lungs, fluid overload, or viral pneumonia.12PubMed. Distinguishing the Causes of Pulmonary Infiltrates in Patients With Acute Leukemia In practice, making the right call often requires getting tissue from the lung.
How the Diagnosis Gets Confirmed
Bronchoscopy, a procedure that threads a camera into the airways, is the most common way to sample the lungs in leukemia patients. Using this tool, doctors can wash out a segment of the lung with fluid (bronchoalveolar lavage, or BAL) and collect the cells that rinse back, or they can snip a small tissue sample through the airway wall (transbronchial biopsy). In pediatric leukemia patients with lung infiltrates, positive diagnostic results were obtained in about 69% of BAL procedures and 46% of biopsy procedures, and both led to changes in treatment, particularly in which antimicrobial drugs were used.13PubMed Central. Safety and benefits of bronchoalveolar lavage and lung biopsy in the management of pulmonary infiltrates in children with leukemia Complications like minor bleeding and temporary drops in oxygen levels did occur but resolved without lasting harm.
When leukemic infiltration is confirmed on biopsy, the response to chemotherapy can serve as further proof. In cases of localized leukemic lung infiltrates, diagnosis via transbronchial biopsy was confirmed by complete clearance of the lung abnormalities once chemotherapy was given.14PubMed. Localized leukemic pulmonary infiltrates. Diagnosis by bronchoscopy and resolution with therapy That therapeutic response helps clinicians feel confident that what they saw on imaging was in fact leukemia, not infection.
Pleural Effusions and Fluid Around the Lungs
Leukemia can also affect the pleural space, the thin gap between the lungs and the chest wall. When leukemia cells invade this space, fluid accumulates, pressing on the lung and making it harder to breathe. Pleural effusions in leukemia can show up as the very first sign of the disease. In one documented case, a young woman presented with a one-sided pleural effusion, and examination of the fluid revealed malignant cells that turned out to be AML.15PubMed Central. Leukaemic pleural effusion as a manifestation of acute myeloid leukaemia: a case report and review of literature The fluid can be analyzed under a microscope and tested with special stains that identify the specific type of leukemia cells present.16PubMed. Acute myeloid leukemia with myelodysplasia-related changes with erythroid differentiation involving pleural fluid: a case report and brief cytopathologic review
Not every pleural effusion in a leukemia patient is caused by the leukemia itself. Heart failure, kidney problems, infections, and low protein levels in the blood can all produce fluid around the lungs. Distinguishing leukemic effusions from these other causes typically requires sending the fluid for cell analysis.
Bleeding Into the Lungs
Diffuse alveolar hemorrhage, or widespread bleeding into the air sacs, is one of the most dangerous lung complications of leukemia. It happens when blood leaks into the spaces meant for air, filling them and making oxygen exchange nearly impossible. This is a life-threatening emergency.
Leukemia patients are especially prone to this complication for several overlapping reasons: their platelet counts are often very low because the bone marrow is overrun with cancer cells, they frequently have problems with blood clotting, and they may be on blood thinners because of the high rate of blood clots seen in this population.17PubMed. Diffuse Alveolar Hemorrhage in Acute Myeloid Leukemia In acute promyelocytic leukemia (APL), a specific subtype, bleeding into the lungs was historically a common cause of death, driven by a clotting disorder that the disease itself causes. Treatment with a drug called ATRA (all-trans retinoic acid) has transformed outcomes for APL, but ATRA itself can, in rare cases, trigger a syndrome that involves lung problems, including hemorrhage.18PubMed. Diffuse alveolar hemorrhage in acute promyelocytic leukemia patients treated with ATRA–a manifestation of the basic disease or the treatment
Although diffuse alveolar hemorrhage most commonly develops as a complication during treatment, it can occasionally be the very first sign that something is wrong. Case reports describe patients presenting with respiratory failure from lung bleeding who were only then discovered to have AML.19PubMed Central. Diffuse Alveolar Hemorrhage as the Initial Manifestation of Acute Myelomonocytic Leukemia
When Breathing Fails Entirely
ARDS represents the extreme end of lung involvement. Whether the trigger is leukemic infiltration, bleeding, infection, or a combination, the result is the same: the lungs become so stiff and fluid-filled that they cannot deliver enough oxygen even with mechanical ventilation. A nationwide study of ARDS in patients with blood cancers found that having lymphoma or acute leukemia, along with factors like advanced age, organ failure, invasive fungal infection, and septic shock, independently predicted death.20PubMed Central. Acute respiratory distress syndrome in patients with hematological malignancies: a one-year retrospective nationwide cohort study
For patients whose lungs fail despite maximal ventilator support, extracorporeal membrane oxygenation (ECMO), a machine that takes over the work of the lungs by oxygenating blood outside the body, has been used as a bridge to recovery. In a small series of four AML patients who developed ARDS during induction chemotherapy and were placed on ECMO, all completed their chemotherapy while on the machine. Two survived to undergo stem cell transplant, giving a one-year survival rate of 50%.21PubMed. Salvage extracorporeal membrane oxygenation in induction-associated acute respiratory distress syndrome in acute leukemia patients: A case series These are extreme measures reserved for patients who still have a realistic chance of beating the underlying leukemia if they can get through the respiratory crisis.
Granulocytic Sarcoma in the Lung
In rare cases, leukemia cells can form an actual solid mass in the lung rather than spreading diffusely. These tumors are called granulocytic sarcomas (also known as chloromas or myeloid sarcomas), and they represent a collection of immature white blood cells that have clumped together outside the bone marrow. One documented case involved a lung mass found on chest imaging that was confirmed as a granulocytic sarcoma through needle biopsy and then treated with a combination of chemotherapy and radiation.22PubMed Central. An unusual case of pulmonary granulocytic sarcoma treated with combined chemotherapy and radiation These masses can appear before, during, or after the blood and bone marrow show signs of leukemia, making them an unusual diagnostic puzzle when they show up on a scan without an existing leukemia diagnosis.
Lung Damage From Treatment Itself
Even when leukemia has not directly invaded the lungs, the treatments used to fight it can cause serious lung problems. The lungs are the organ most commonly affected by chemotherapy-related complications, whether from direct drug toxicity, from infections that take hold when the immune system is suppressed, or from immune-mediated reactions.23PubMed Central. Chemotherapy-induced pulmonary complications in cancer: Significance of clinicoradiological correlation These complications can look identical to leukemic lung infiltration on imaging, adding another layer of difficulty to diagnosis.
For patients who undergo a stem cell transplant, the lungs face additional long-term threats. Graft-versus-host disease (GVHD), where the donated immune cells attack the recipient’s body, can target the lungs and cause lasting damage. The hallmark lung problem of chronic GVHD is bronchiolitis obliterans, a condition where the small airways become scarred and narrowed, leading to progressive, often irreversible airflow obstruction. Disease severity ranges from subtle changes detectable only on breathing tests to severe respiratory failure.24PubMed Central. Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD
Beyond bronchiolitis obliterans, interstitial lung diseases have also been reported after stem cell transplants. A large study comparing these two complications found that both occurred mainly in patients with a history of GVHD, but they behaved differently. Patients with interstitial lung disease tended to respond to systemic steroid treatment, while those with bronchiolitis obliterans were more often managed with inhaled steroids and generally saw their lung function stabilize rather than improve.25Bone Marrow Transplantation. Interstitial lung diseases after hematopoietic stem cell transplantation: New pattern of lung chronic graft-versus-host disease? Whether interstitial lung disease after transplant should be formally classified as a form of lung GVHD remains an open question.
Which Types of Leukemia Are Most Likely to Affect the Lungs
Pulmonary involvement can happen with virtually any type of leukemia, but the pattern and likelihood vary. Acute leukemias, particularly AML (and its monocytic variants), carry the highest risk of leukostasis and direct infiltration because the abnormal cells are large, sticky, and circulate in high numbers. CLL, a slower-growing disease, can also infiltrate the lungs, sometimes as an initial presentation and sometimes after years of disease, though it tends to progress less explosively. Pulmonary problems are common across the spectrum of blood cancers, including lymphomas and myelodysplastic syndromes, each with its own characteristic pattern of lung involvement.26PubMed Central. Pulmonary Manifestations in Patients With Hematologic Malignancies: In Pursuit of an Accurate Diagnosis
Monocytic leukemia deserves particular mention. In the study of ICU patients described earlier, all 20 patients who presented with rapidly worsening respiratory distress had monocytic leukemia, and many experienced further deterioration after chemotherapy was started, likely due to a wave of inflammation as the cancer cells broke apart in the lungs.3American Journal of Respiratory and Critical Care Medicine. Acute Monocytic Leukemia Presenting as Acute Respiratory Failure This paradoxical worsening with treatment is something ICU teams have to anticipate and manage aggressively.